1. 0375 A Novel Dual Orexin Receptor Antagonist (ACT-541468) to Treat Insomnia: A Randomized, Double-Blind, Placebo-Controlled, Active-Reference Phase 2 Study. (12th April 2019) Authors: Dauvilliers, Yves; Zammit, Gary; Fietze, Ingo; Mayleben, David; Kinter, Dalma Seboek; Pain, Scott; Hedner, Jan Journal: Sleep Issue: Volume 42(2019)Supplement 1 Page Start: A152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 0407 ACT-541468, A Dual Orexin Receptor Antagonist, For The Treatment Of Insomnia Disorder: A Randomized, Double-Blind, Placebo-Controlled, 5-Period, 5-Treatment Crossover Dose-Response Phase 2 Study In The Elderly. (12th April 2019) Authors: Zammit, Gary; Dauvilliers, Yves; Pain, Scott; Kinter, Dalma Seboek; Kunz, Dieter Journal: Sleep Issue: Volume 42(2019)Supplement 1 Page Start: A165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 0455 The Insomnia Daytime Symptoms and Impacts Questionnaire: An Analysis of Clinically Meaningful Change Using Phase 3 Clinical Trial Data. (25th May 2022) Authors: Phillips-Beyer, Andrea; Kawata, Ariane; Kleinman, Leah; Kinter, Dalma Seboek Journal: Sleep Issue: Volume 45(2022)Supplement 1 Page Start: A201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 344 Daridorexant Improves Total Sleep Time (TST) in Insomnia Patients Without Altering the Proportion of Sleep Stages. (3rd May 2021) Authors: Zammit, Gary; Mayleben, David; Fietze, Ingo; Pain, Scott; Kinter, Dalma Seboek; Gimona, Alberto; Dauvilliers, Yves Journal: Sleep Issue: Volume 44(2021)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 347 Daridorexant is Safe and Improves Both Sleep and Daytime Functioning in Elderly Patients with Insomnia. (3rd May 2021) Authors: Fietze, Ingo; Bassetti, Claudio; Mayleben, David; Gimona, Alberto; Pain, Scott; Kinter, Dalma Seboek Journal: Sleep Issue: Volume 44(2021)Supplement 2 Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 348 Absence of Withdrawal Symptoms and Rebound Insomnia Upon Discontinuation of Daridorexant in Patients with Insomnia. (3rd May 2021) Authors: Leger, Damien; Fietze, Ingo; Pain, Scott; Kinter, Dalma Seboek; Flamion, Bruno; Mignot, Emmanuel Journal: Sleep Issue: Volume 44(2021)Supplement 2 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials. Issue 2 (February 2022) Authors: Mignot, Emmanuel; Mayleben, David; Fietze, Ingo; Leger, Damien; Zammit, Gary; Bassetti, Claudio L A; Pain, Scott; Kinter, Dalma Seboek; Roth, Thomas Journal: Lancet neurology Issue: Volume 21:Issue 2(2022) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗